Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional...

Area of Science:

• Biochemistry
• Pharmacology
• Genetics

Background:

• The human flavin-containing monooxygenase (form 3) (FMO3) enzyme is crucial for metabolizing drugs, xenobiotics, and endogenous compounds.
• FMO3 is the predominant form in adult human liver, responsible for most FMO-mediated metabolism.
• Unlike cytochrome P450 enzymes, FMO3 is not inducible, suggesting genetic factors are primary drivers of metabolic variation.

Purpose of the Study:

• To explore the substrate specificity and known metabolic pathways of human FMO3.
• To investigate the role of genetic variations in FMO3, particularly in relation to trimethylaminuria.
• To understand the implications of FMO3 allelic variation on drug and chemical metabolism variability.

Main Methods:

• Review of existing literature on FMO3 function, substrate requirements, and genetic variants.
• Analysis of case studies involving FMO3 mutations and associated conditions like trimethylaminuria.
• Comparison of FMO3 expression and inducibility with other metabolic enzymes like cytochrome P450.

Main Results:

• FMO3 exhibits specific substrate structural requirements for N-oxygenation.
• Rare FMO3 mutations cause deficient trimethylamine N-oxygenation, leading to trimethylaminuria (fish-odor syndrome).
• Common FMO3 variants are identified, and allelic variation is proposed to influence interindividual and interethnic metabolic differences.

Conclusions:

• Interindividual differences in FMO3-mediated metabolism are primarily due to genetic factors, not environmental influences.
• FMO3 mutations provide insights into metabolic pathways and disease mechanisms.
• FMO3 allelic variation likely contributes to variability in drug response and chemical exposure, highlighting its role as a protective environmental gene.